Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for MLX_USF2_USF1_PAX2
Z-value: 4.86
Motif logo
Transcription factors associated with MLX_USF2_USF1_PAX2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MLX
|
ENSG00000108788.12 | MLX |
|
USF2
|
ENSG00000105698.16 | USF2 |
|
USF1
|
ENSG00000158773.14 | USF1 |
|
PAX2
|
ENSG00000075891.23 | PAX2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| USF2 | hg38_v1_chr19_+_35268921_35268988 | 0.30 | 6.5e-06 | Click! |
| MLX | hg38_v1_chr17_+_42567084_42567125 | 0.19 | 4.3e-03 | Click! |
| PAX2 | hg38_v1_chr10_+_100746197_100746220 | 0.07 | 3.3e-01 | Click! |
Activity profile of MLX_USF2_USF1_PAX2 motif
Sorted Z-values of MLX_USF2_USF1_PAX2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of MLX_USF2_USF1_PAX2
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 13.6 | 40.9 | GO:0070429 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
| 8.5 | 25.5 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 7.7 | 23.0 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 6.8 | 47.5 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 6.0 | 18.0 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
| 5.9 | 17.6 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 5.4 | 54.5 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 5.2 | 41.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 4.9 | 14.6 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 4.0 | 12.0 | GO:0097698 | telomere maintenance via base-excision repair(GO:0097698) |
| 3.9 | 11.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 3.7 | 14.9 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 3.7 | 11.2 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 3.7 | 22.2 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 3.7 | 11.1 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 3.4 | 10.2 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 3.3 | 9.9 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 3.3 | 9.8 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 3.2 | 12.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 3.1 | 27.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 2.8 | 14.2 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 2.8 | 11.1 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 2.8 | 16.5 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 2.7 | 21.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 2.6 | 18.3 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 2.6 | 10.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 2.6 | 10.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 2.5 | 17.8 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 2.5 | 7.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 2.5 | 22.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 2.4 | 26.9 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 2.4 | 7.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 2.4 | 14.2 | GO:1900369 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
| 2.3 | 7.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 2.3 | 9.2 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 2.2 | 6.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 2.2 | 6.7 | GO:0070079 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 2.2 | 6.6 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 2.2 | 34.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 2.1 | 8.4 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
| 2.1 | 20.9 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 2.0 | 10.1 | GO:0030242 | pexophagy(GO:0030242) |
| 1.9 | 13.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 1.9 | 9.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 1.7 | 3.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 1.6 | 24.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 1.6 | 8.2 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 1.6 | 53.6 | GO:0090383 | phagosome acidification(GO:0090383) |
| 1.6 | 8.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.6 | 6.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 1.6 | 11.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 1.6 | 6.2 | GO:1904799 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 1.6 | 6.2 | GO:0043335 | protein unfolding(GO:0043335) |
| 1.5 | 6.1 | GO:0002384 | hepatic immune response(GO:0002384) |
| 1.5 | 4.6 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 1.5 | 4.6 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.5 | 4.5 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 1.5 | 7.6 | GO:1903232 | melanosome assembly(GO:1903232) |
| 1.5 | 9.0 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 1.5 | 4.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 1.5 | 7.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 1.4 | 8.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 1.4 | 5.5 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 1.4 | 6.8 | GO:0015808 | L-alanine transport(GO:0015808) |
| 1.3 | 4.0 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 1.3 | 5.3 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 1.3 | 4.0 | GO:1902728 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 1.3 | 10.5 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.3 | 10.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 1.3 | 16.9 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
| 1.3 | 5.0 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 1.2 | 17.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 1.2 | 4.9 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 1.2 | 3.6 | GO:0002368 | B cell cytokine production(GO:0002368) |
| 1.2 | 3.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 1.2 | 3.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 1.2 | 7.2 | GO:0097338 | response to clozapine(GO:0097338) |
| 1.2 | 11.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 1.2 | 3.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 1.1 | 5.4 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 1.1 | 3.2 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 1.0 | 21.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 1.0 | 2.0 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 1.0 | 10.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 1.0 | 10.2 | GO:0032264 | IMP salvage(GO:0032264) |
| 1.0 | 4.0 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 1.0 | 11.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 1.0 | 3.0 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 1.0 | 3.9 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 1.0 | 1.0 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
| 1.0 | 7.7 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.9 | 5.6 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.9 | 4.6 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
| 0.9 | 17.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.9 | 11.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.9 | 3.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.9 | 7.0 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.9 | 3.4 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.8 | 5.9 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.8 | 4.2 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.8 | 5.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.8 | 6.8 | GO:0090382 | phagosome maturation(GO:0090382) |
| 0.8 | 9.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.8 | 4.9 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.8 | 8.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.8 | 16.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 0.8 | 7.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.8 | 2.4 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.8 | 20.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.8 | 4.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.8 | 6.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.8 | 20.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.7 | 2.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.7 | 5.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.7 | 4.5 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.7 | 2.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 0.7 | 1.5 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.7 | 2.1 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.7 | 6.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.7 | 5.5 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.7 | 2.8 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.7 | 2.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.7 | 4.0 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.7 | 2.0 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.7 | 2.6 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.7 | 4.6 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.6 | 1.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.6 | 3.8 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.6 | 3.2 | GO:0005985 | sucrose metabolic process(GO:0005985) |
| 0.6 | 2.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.6 | 1.9 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.6 | 5.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.6 | 6.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.6 | 15.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.6 | 6.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.6 | 6.7 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.6 | 3.6 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.6 | 3.0 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.6 | 8.4 | GO:0032438 | melanosome organization(GO:0032438) |
| 0.6 | 20.9 | GO:0007143 | female meiotic division(GO:0007143) |
| 0.6 | 2.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.6 | 10.1 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.6 | 4.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.6 | 2.3 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.6 | 1.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.6 | 3.9 | GO:0045007 | depurination(GO:0045007) |
| 0.6 | 2.8 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.5 | 1.1 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.5 | 3.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.5 | 33.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.5 | 8.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.5 | 2.1 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.5 | 5.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.5 | 3.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.5 | 4.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.5 | 1.6 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.5 | 2.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.5 | 1.5 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.5 | 3.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.5 | 1.5 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.5 | 1.5 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.5 | 6.5 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.5 | 4.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.5 | 2.0 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.5 | 4.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.5 | 2.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.5 | 2.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.5 | 1.0 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
| 0.5 | 11.4 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.5 | 19.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.5 | 0.9 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
| 0.5 | 0.5 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 0.5 | 5.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.5 | 1.9 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.5 | 2.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.5 | 0.5 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.5 | 4.1 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.5 | 2.7 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.4 | 1.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 | 4.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.4 | 12.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.4 | 1.3 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.4 | 3.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.4 | 1.3 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.4 | 1.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.4 | 5.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.4 | 1.7 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.4 | 3.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.4 | 2.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 | 2.0 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.4 | 0.4 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
| 0.4 | 4.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.4 | 2.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.4 | 5.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.4 | 1.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.4 | 8.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.4 | 6.6 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.4 | 3.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.4 | 10.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.4 | 1.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.4 | 3.0 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.4 | 1.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.4 | 4.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.4 | 6.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.4 | 2.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 | 0.7 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 0.4 | 1.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.4 | 4.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.4 | 1.1 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.4 | 1.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.4 | 5.0 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.4 | 1.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.4 | 1.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.4 | 2.8 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.4 | 1.8 | GO:0051029 | rRNA transport(GO:0051029) |
| 0.4 | 0.7 | GO:2000077 | negative regulation of type B pancreatic cell development(GO:2000077) |
| 0.4 | 2.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.4 | 7.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.3 | 1.7 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
| 0.3 | 0.3 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 0.3 | 11.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
| 0.3 | 4.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.3 | 1.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.3 | 2.0 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.3 | 1.3 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.3 | 2.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.3 | 2.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.3 | 2.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 | 4.9 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
| 0.3 | 1.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.3 | 1.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.3 | 21.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.3 | 3.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.3 | 1.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.3 | 1.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.3 | 1.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.3 | 0.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.3 | 1.5 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 | 0.8 | GO:0070487 | monocyte aggregation(GO:0070487) |
| 0.3 | 0.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 | 0.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 | 2.2 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
| 0.3 | 5.0 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.3 | 6.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.3 | 1.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.3 | 3.3 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
| 0.3 | 0.8 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 0.3 | 11.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.3 | 11.8 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.3 | 2.2 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.3 | 0.3 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.3 | 0.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 | 17.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.3 | 0.8 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.3 | 4.1 | GO:0040032 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.3 | 1.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 | 29.5 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.2 | 0.7 | GO:0021658 | rhombomere morphogenesis(GO:0021593) rhombomere 3 morphogenesis(GO:0021658) |
| 0.2 | 4.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.2 | 2.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.2 | 3.2 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.2 | 1.0 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.2 | 6.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.2 | 2.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.2 | 1.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.2 | 1.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.2 | 0.5 | GO:0002879 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.2 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.2 | 0.7 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 0.2 | 3.8 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.2 | 4.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.2 | 0.5 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 0.2 | 0.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.2 | 1.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 1.7 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 | 1.3 | GO:0044268 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 | 3.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.2 | 3.7 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.2 | 1.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 0.4 | GO:0060525 | prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.2 | 2.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 | 2.6 | GO:0015074 | DNA integration(GO:0015074) |
| 0.2 | 2.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.2 | 1.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 | 3.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 | 0.4 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.2 | 0.6 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
| 0.2 | 7.0 | GO:0007032 | endosome organization(GO:0007032) |
| 0.2 | 0.4 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
| 0.2 | 1.5 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.2 | 2.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 | 2.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.2 | 1.9 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.2 | 3.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.2 | 0.6 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.2 | 0.4 | GO:0086053 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.2 | 0.9 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.2 | 1.3 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.2 | 3.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.2 | 0.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.2 | 5.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.2 | 2.7 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.2 | 4.4 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.2 | 0.5 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.2 | 5.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.2 | 12.4 | GO:0048678 | response to axon injury(GO:0048678) |
| 0.2 | 15.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 | 0.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.2 | 0.5 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.2 | 1.5 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.2 | 6.3 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.2 | 2.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.2 | 0.8 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 | 2.4 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
| 0.2 | 8.3 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.2 | 1.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.2 | 11.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.2 | 17.4 | GO:0015992 | proton transport(GO:0015992) |
| 0.2 | 0.5 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.2 | 2.9 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
| 0.2 | 1.9 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.2 | 1.0 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 | 7.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.2 | 0.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.2 | 0.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.2 | 2.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.2 | 0.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.2 | 1.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 3.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.1 | 1.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 6.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 1.0 | GO:0015846 | polyamine transport(GO:0015846) |
| 0.1 | 1.0 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.1 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 80.0 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.1 | 4.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.1 | 1.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 3.5 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
| 0.1 | 0.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.1 | 0.4 | GO:0072319 | vesicle uncoating(GO:0072319) |
| 0.1 | 1.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 0.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 | 0.9 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 | 4.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 1.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.7 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.1 | 1.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 5.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 0.5 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.1 | 2.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 1.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 1.6 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.1 | 0.8 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 | 6.9 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 | 4.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 | 0.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 1.1 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
| 0.1 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 | 1.2 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 1.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 0.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 | 0.3 | GO:0042701 | progesterone secretion(GO:0042701) regulation of progesterone secretion(GO:2000870) |
| 0.1 | 5.5 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 2.1 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 3.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 1.7 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 6.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 0.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 1.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.8 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 6.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 3.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 | 1.2 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
| 0.1 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 | 0.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 1.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 3.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.7 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.1 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 12.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 0.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 | 3.2 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 | 1.3 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.1 | 1.9 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 1.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 1.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 0.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.1 | 0.8 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 1.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 1.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 2.3 | GO:0043473 | pigmentation(GO:0043473) |
| 0.1 | 1.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.1 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 0.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 1.8 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 | 2.0 | GO:0001510 | RNA methylation(GO:0001510) |
| 0.1 | 5.2 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 | 1.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 1.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 0.5 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.1 | 2.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
| 0.1 | 0.4 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 1.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 | 13.9 | GO:0006457 | protein folding(GO:0006457) |
| 0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 4.0 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.1 | 2.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 | 2.9 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.1 | 0.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.1 | 1.0 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.1 | 0.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.1 | 1.1 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
| 0.1 | 0.2 | GO:0044861 | protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
| 0.1 | 0.9 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.1 | 1.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
| 0.1 | 1.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.8 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 1.0 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 0.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.0 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.0 | 0.5 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.0 | 0.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.0 | 1.2 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.0 | 0.8 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
| 0.0 | 0.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 | 0.1 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.0 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.0 | 0.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.0 | 2.2 | GO:0009583 | detection of light stimulus(GO:0009583) |
| 0.0 | 0.9 | GO:0006101 | citrate metabolic process(GO:0006101) |
| 0.0 | 1.3 | GO:0016197 | endosomal transport(GO:0016197) |
| 0.0 | 0.1 | GO:0034242 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.0 | 1.1 | GO:0008217 | regulation of blood pressure(GO:0008217) |
| 0.0 | 0.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 | 0.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 | 0.8 | GO:0019915 | lipid storage(GO:0019915) |
| 0.0 | 0.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 | 0.9 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.0 | 0.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 | 0.5 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.0 | 1.6 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
| 0.0 | 1.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 | 0.3 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 | 0.8 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 1.1 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.0 | 0.9 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.0 | 0.4 | GO:0048265 | response to pain(GO:0048265) |
| 0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.0 | 1.2 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
| 0.0 | 1.0 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 1.0 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.0 | 0.4 | GO:0002456 | T cell mediated immunity(GO:0002456) |
| 0.0 | 0.2 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 1.8 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 | 0.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.0 | 0.7 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.2 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.0 | 0.6 | GO:0044070 | regulation of anion transport(GO:0044070) |
| 0.0 | 0.2 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 | 0.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.7 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 | 0.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 3.8 | GO:0006897 | endocytosis(GO:0006897) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.2 | 35.8 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 6.9 | 55.4 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 4.0 | 47.7 | GO:0071203 | WASH complex(GO:0071203) |
| 3.7 | 11.1 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 3.3 | 23.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 3.2 | 25.7 | GO:0000322 | storage vacuole(GO:0000322) |
| 3.2 | 12.7 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 3.1 | 3.1 | GO:0019034 | viral replication complex(GO:0019034) |
| 3.0 | 18.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 2.9 | 11.6 | GO:0033263 | CORVET complex(GO:0033263) |
| 2.8 | 25.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 2.6 | 10.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 2.5 | 17.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 2.4 | 11.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 2.2 | 8.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 2.0 | 14.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 2.0 | 7.8 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 1.9 | 22.8 | GO:0030897 | HOPS complex(GO:0030897) |
| 1.7 | 22.5 | GO:0097413 | Lewy body(GO:0097413) |
| 1.7 | 26.9 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 1.5 | 33.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 1.5 | 8.8 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 1.5 | 21.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 1.4 | 9.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 1.3 | 10.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 1.2 | 6.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 1.1 | 12.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 1.1 | 5.4 | GO:0031082 | BLOC complex(GO:0031082) |
| 1.1 | 4.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 1.0 | 11.3 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 1.0 | 4.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 1.0 | 6.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 1.0 | 2.9 | GO:0055087 | Ski complex(GO:0055087) |
| 0.9 | 8.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.9 | 18.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.9 | 3.6 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.9 | 10.2 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.8 | 4.2 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.8 | 11.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.8 | 9.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.8 | 5.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.8 | 7.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.8 | 3.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.7 | 5.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.7 | 7.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.7 | 15.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.7 | 9.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.7 | 10.2 | GO:0032059 | bleb(GO:0032059) |
| 0.7 | 19.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.7 | 2.0 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.7 | 7.2 | GO:0030904 | retromer complex(GO:0030904) |
| 0.6 | 2.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.6 | 2.6 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.6 | 12.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.6 | 45.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.6 | 17.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.6 | 20.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.6 | 3.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.6 | 1.8 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.6 | 6.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.6 | 2.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.6 | 12.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.6 | 3.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.6 | 1.7 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.6 | 9.5 | GO:0000786 | nucleosome(GO:0000786) |
| 0.6 | 71.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.6 | 5.0 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.5 | 3.8 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.5 | 47.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.5 | 18.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.5 | 2.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.5 | 57.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.5 | 1.0 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
| 0.5 | 8.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.5 | 10.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.5 | 22.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.5 | 3.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.5 | 7.6 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.4 | 4.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.4 | 7.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.4 | 125.4 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.4 | 4.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.4 | 5.7 | GO:0001741 | XY body(GO:0001741) |
| 0.4 | 1.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.4 | 4.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.4 | 7.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.4 | 1.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.3 | 2.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.3 | 2.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.3 | 2.0 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.3 | 0.9 | GO:0034657 | GID complex(GO:0034657) |
| 0.3 | 6.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.3 | 41.7 | GO:0016605 | PML body(GO:0016605) |
| 0.3 | 2.1 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 5.0 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.3 | 83.7 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.3 | 3.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.3 | 7.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.3 | 0.8 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.3 | 1.1 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.3 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.3 | 5.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.2 | 13.1 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.2 | 8.7 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.2 | 9.5 | GO:0016592 | mediator complex(GO:0016592) |
| 0.2 | 2.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 1.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.2 | 100.1 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.2 | 1.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.2 | 2.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 0.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.2 | 0.8 | GO:0002177 | manchette(GO:0002177) |
| 0.2 | 1.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.2 | 32.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.2 | 3.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.2 | 1.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.2 | 2.0 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 2.7 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.2 | 27.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.2 | 5.6 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.2 | 1.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.2 | 3.4 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 0.8 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.2 | 3.2 | GO:0043219 | lateral loop(GO:0043219) |
| 0.2 | 0.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.2 | 17.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.2 | 16.0 | GO:0005814 | centriole(GO:0005814) |
| 0.2 | 7.9 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.2 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.2 | 12.0 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 1.4 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.1 | 3.7 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.1 | 14.6 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 13.2 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 3.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 2.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 1.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 1.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 0.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 3.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 1.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 4.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.4 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.1 | 2.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 4.3 | GO:0005657 | replication fork(GO:0005657) |
| 0.1 | 1.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.1 | 7.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 11.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.1 | 0.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 13.6 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 1.4 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 1.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 4.8 | GO:0030426 | growth cone(GO:0030426) |
| 0.1 | 32.4 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 1.4 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 0.3 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.1 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 17.3 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 1.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 2.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 0.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 0.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 3.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 2.2 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.1 | 0.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 0.3 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.0 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.0 | 0.4 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.0 | 7.0 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.0 | 2.4 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 3.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 4.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 1.1 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 2.5 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.0 | 2.4 | GO:0030175 | filopodium(GO:0030175) |
| 0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 14.8 | GO:0045202 | synapse(GO:0045202) |
| 0.0 | 2.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.0 | 0.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.0 | 0.7 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 0.3 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 0.2 | GO:0005922 | connexon complex(GO:0005922) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.8 | 54.4 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 6.6 | 19.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 6.4 | 25.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 5.0 | 20.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 4.9 | 14.6 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 4.0 | 12.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 3.7 | 11.1 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 3.7 | 22.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 3.6 | 49.9 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 3.3 | 16.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 3.2 | 12.8 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
| 3.2 | 15.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 3.0 | 12.0 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 2.8 | 11.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 2.6 | 33.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 2.6 | 35.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 2.6 | 35.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 2.6 | 7.7 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 2.5 | 7.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 2.4 | 14.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 2.3 | 13.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 2.3 | 6.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 2.2 | 17.9 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 2.2 | 6.7 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 2.0 | 6.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 2.0 | 6.1 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 1.9 | 7.7 | GO:0043273 | CTPase activity(GO:0043273) |
| 1.9 | 9.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 1.8 | 11.1 | GO:0034046 | poly(G) binding(GO:0034046) |
| 1.8 | 9.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 1.8 | 14.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 1.8 | 5.3 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 1.8 | 37.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 1.7 | 20.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 1.6 | 6.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.6 | 25.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 1.6 | 6.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 1.6 | 7.9 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.6 | 34.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 1.5 | 34.1 | GO:0044769 | hydrogen-exporting ATPase activity(GO:0036442) ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 1.5 | 4.6 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 1.5 | 30.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 1.5 | 7.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 1.4 | 7.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 1.4 | 5.5 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 1.3 | 11.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 1.3 | 11.4 | GO:0043426 | MRF binding(GO:0043426) |
| 1.2 | 4.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 1.2 | 3.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 1.2 | 3.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 1.2 | 3.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 1.1 | 4.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.1 | 8.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 1.1 | 3.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 1.1 | 3.2 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 1.1 | 3.2 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 1.0 | 3.9 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.9 | 5.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.9 | 3.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.9 | 4.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.8 | 13.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.8 | 4.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.8 | 66.0 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.8 | 5.3 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.7 | 5.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.7 | 2.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.7 | 3.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.7 | 20.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.7 | 4.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.7 | 3.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.7 | 10.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.7 | 4.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.6 | 12.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.6 | 3.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.6 | 3.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 0.6 | 4.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.6 | 20.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.6 | 4.2 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.6 | 1.7 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.6 | 2.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.6 | 27.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.6 | 1.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.6 | 14.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.5 | 11.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.5 | 2.1 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.5 | 16.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.5 | 3.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.5 | 10.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.5 | 2.0 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.5 | 8.9 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.5 | 5.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.5 | 2.9 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.5 | 1.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.5 | 7.9 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.5 | 1.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.5 | 4.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.5 | 1.8 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.5 | 4.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.4 | 2.2 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.4 | 4.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.4 | 4.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.4 | 1.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.4 | 2.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.4 | 2.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.4 | 3.5 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.4 | 3.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.4 | 0.4 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 0.4 | 6.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.4 | 1.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.4 | 2.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.4 | 1.6 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.4 | 1.6 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.4 | 2.0 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.4 | 5.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.4 | 2.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.4 | 7.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.4 | 5.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.4 | 1.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.4 | 4.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.4 | 2.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.4 | 30.3 | GO:0019003 | GDP binding(GO:0019003) |
| 0.4 | 1.1 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.4 | 1.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.4 | 19.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.4 | 7.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 2.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.3 | 2.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.3 | 3.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.3 | 2.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 2.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.3 | 8.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.3 | 3.0 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.3 | 1.0 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 0.3 | 1.3 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.3 | 1.6 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.3 | 7.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.3 | 7.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.3 | 20.8 | GO:0070888 | E-box binding(GO:0070888) |
| 0.3 | 6.4 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.3 | 2.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.3 | 2.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.3 | 3.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.3 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.3 | 9.7 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.3 | 2.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.3 | 3.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.3 | 3.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.3 | 8.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.3 | 99.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.3 | 1.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.3 | 6.8 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.3 | 5.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.3 | 3.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.3 | 10.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.3 | 9.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 33.7 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.2 | 2.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 28.6 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.2 | 10.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.2 | 1.4 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.2 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.2 | 5.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 0.7 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.2 | 0.9 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
| 0.2 | 4.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.2 | 2.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.2 | 1.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.2 | 1.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.2 | 2.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.2 | 2.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.2 | 5.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.2 | 2.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.2 | 0.6 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 0.2 | 6.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 1.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.2 | 2.3 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.2 | 1.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.2 | 3.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.2 | 16.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.2 | 1.9 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.2 | 3.0 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.2 | 0.5 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.2 | 1.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 4.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 0.9 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.2 | 0.5 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.2 | 1.2 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.2 | 1.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.2 | 4.1 | GO:0051430 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.2 | 1.0 | GO:0070728 | leucine binding(GO:0070728) |
| 0.2 | 4.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.2 | 9.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.2 | 20.8 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.2 | 0.7 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) L-glutamine transmembrane transporter activity(GO:0015186) alanine transmembrane transporter activity(GO:0022858) |
| 0.2 | 2.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.2 | 1.9 | GO:0031386 | protein tag(GO:0031386) |
| 0.2 | 3.9 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 3.7 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.2 | 1.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 1.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 0.5 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.2 | 1.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.2 | 0.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.2 | 1.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.2 | 10.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.2 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.2 | 1.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.2 | 2.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.2 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.1 | 0.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 2.9 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 1.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.1 | 1.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.1 | 1.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 0.7 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.1 | 1.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 6.5 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
| 0.1 | 1.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 0.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 25.1 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.1 | 1.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 2.9 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
| 0.1 | 1.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.1 | 0.7 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 1.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
| 0.1 | 0.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.1 | 1.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 8.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 1.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.1 | 4.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 2.9 | GO:0004629 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
| 0.1 | 1.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 1.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.1 | 2.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.7 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.1 | 3.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 1.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.1 | 0.9 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.1 | 0.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 2.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 2.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.5 | GO:0004803 | transposase activity(GO:0004803) |
| 0.1 | 2.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.1 | 1.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 26.9 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.1 | 1.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.1 | 0.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.1 | 0.4 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.1 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.1 | 0.6 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.1 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 3.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 4.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 1.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.1 | 11.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.1 | 3.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 7.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 1.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.1 | 2.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 1.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 3.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 29.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.1 | 11.3 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 2.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 1.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 3.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 1.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 1.7 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 30.4 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
| 0.1 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.1 | 8.1 | GO:0016747 | transferase activity, transferring acyl groups other than amino-acyl groups(GO:0016747) |
| 0.1 | 1.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.1 | 0.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.1 | 1.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
| 0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 0.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 1.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.0 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.0 | 0.4 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.0 | 1.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.0 | 0.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 2.6 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 1.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 0.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 0.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.0 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.0 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.0 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 1.9 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.8 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.0 | 0.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 0.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 1.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.0 | 0.6 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.0 | 0.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 44.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.8 | 10.1 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.7 | 9.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.6 | 29.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.6 | 24.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.6 | 29.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.6 | 29.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.5 | 27.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.5 | 12.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.4 | 9.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.4 | 1.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.4 | 16.4 | PID EPO PATHWAY | EPO signaling pathway |
| 0.4 | 23.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.4 | 16.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.4 | 8.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.3 | 8.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.3 | 17.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.3 | 39.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.3 | 6.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.3 | 4.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.3 | 27.9 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.3 | 3.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.3 | 5.5 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.3 | 3.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.3 | 7.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.3 | 6.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 10.2 | PID MYC PATHWAY | C-MYC pathway |
| 0.3 | 8.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.3 | 13.2 | PID FOXO PATHWAY | FoxO family signaling |
| 0.3 | 2.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 61.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 6.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 6.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.2 | 1.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 5.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.2 | 9.2 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.2 | 3.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.2 | 7.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 9.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.2 | 11.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.2 | 13.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.2 | 25.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.2 | 5.2 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 3.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 4.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 2.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 3.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 3.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 12.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 5.9 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 0.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 2.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 1.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 4.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 3.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 1.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 0.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 1.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 1.1 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 3.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 1.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 1.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 2.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 1.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.0 | 0.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.5 | 20.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 2.0 | 60.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 1.8 | 27.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 1.5 | 20.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 1.2 | 94.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 1.2 | 17.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 1.2 | 23.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 1.1 | 9.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.0 | 15.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.9 | 42.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.9 | 9.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.8 | 48.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.6 | 13.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.6 | 10.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.6 | 13.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.6 | 7.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.6 | 3.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.5 | 4.9 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.5 | 14.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.5 | 8.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.5 | 10.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.5 | 41.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.4 | 3.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.4 | 6.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.4 | 6.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.4 | 6.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.4 | 0.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.4 | 6.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.3 | 10.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.3 | 2.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.3 | 6.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.3 | 6.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.3 | 2.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.3 | 3.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.3 | 2.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.3 | 5.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.3 | 1.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.3 | 19.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.3 | 3.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.3 | 5.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.3 | 4.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.3 | 6.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 3.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 3.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 36.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.2 | 3.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 4.7 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.2 | 15.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 8.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.2 | 10.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.2 | 14.8 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.2 | 45.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.2 | 3.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.2 | 8.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.2 | 1.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.2 | 4.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.2 | 8.0 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.2 | 1.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 3.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 2.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 4.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.1 | 2.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.1 | 8.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 4.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 17.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 2.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.1 | 12.1 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.1 | 3.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 1.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 2.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.1 | 2.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 1.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 1.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 1.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.1 | 1.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 5.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 1.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 2.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 2.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.1 | 8.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 2.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 2.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 1.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 4.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 2.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 2.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 1.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 2.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 5.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 5.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.1 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 0.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 2.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 2.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 3.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.0 | 6.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.0 | 0.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 0.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 2.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 0.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 2.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 0.0 | 0.6 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.0 | 0.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 1.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |